Aspire Capital Advisors LLC Merck & Co., Inc. Transaction History
Aspire Capital Advisors LLC
- $289 Million
- Q1 2024
A detailed history of Aspire Capital Advisors LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Aspire Capital Advisors LLC holds 2,135 shares of MRK stock, worth $268,540. This represents 0.1% of its overall portfolio holdings.
Number of Shares
2,135
Previous 2,160
1.16%
Holding current value
$268,540
Previous $235,000
19.57%
% of portfolio
0.1%
Previous 0.1%
Shares
5 transactions
Others Institutions Holding MRK
# of Institutions
3,770Shares Held
1.87BCall Options Held
17.3MPut Options Held
14.8M-
Vanguard Group Inc Valley Forge, PA243MShares$30.6 Billion0.65% of portfolio
-
Black Rock Inc. New York, NY207MShares$26 Billion0.65% of portfolio
-
State Street Corp Boston, MA117MShares$14.8 Billion0.7% of portfolio
-
Wellington Management Group LLP Boston, MA86.3MShares$10.9 Billion2.07% of portfolio
-
Geode Capital Management, LLC Boston, MA56.4MShares$7.1 Billion0.7% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $319B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...